Consolidated Statement of Cash Flows
For the period ended 31 December |
|
|
|
in CHF 1,000 |
Note |
2020 |
2019 |
|
|
|
|
Profit for the period |
|
176,761 |
125,004 |
|
|
|
|
Adjustments for: |
|
|
|
Depreciation, amortization and impairment |
15, 16, 22 |
55,162 |
51,265 |
Total finance result, net |
9 |
–80,225 |
–35,429 |
Share of result of joint ventures and associated companies |
17 |
–764 |
88 |
Tax expense |
|
37,042 |
29,346 |
Other non-cash items 1) |
|
27,510 |
25,208 |
Change in trade receivables 1) |
|
126,083 |
–388,990 |
Change in other receivables, prepayments and contract assets 1) |
|
–6,317 |
70,200 |
Change in trade and other payables 1) |
|
97,903 |
458,674 |
Change in accrued expenses and contract liabilities 1) |
|
–117,493 |
–86,581 |
Changes in provisions 1) |
|
–4,990 |
–309 |
Income taxes paid |
|
–34,403 |
–32,199 |
|
|
|
|
Net cash generated from/(used in) operating activities |
|
276,269 |
216,277 |
Purchases of tangible and intangible assets |
15, 16 |
–22,822 |
–20,687 |
Proceeds from sale of tangible and intangible assets |
|
760 |
109 |
Purchases of financial assets |
|
–2,959 |
–7,196 |
Loans granted |
|
–374 |
–1,818 |
Loan repayments received |
|
3,386 |
1,550 |
Interest received |
|
3,297 |
4,389 |
Acquisition of businesses (net of cash) |
3 |
–45,512 |
49,958 |
Acquisition of investment in joint ventures |
17 |
– |
–7,478 |
|
|
|
|
Net cash from/(used) in investing activities |
|
–64,224 |
18,827 |
Proceeds from financial liabilities |
20 |
659,700 |
1,670,956 |
Repayments of financial liabilities |
20 |
–694,397 |
–1,704,803 |
Payment from shareholders |
26 |
– |
15,986 |
Payment of contingent consideration liabilities |
20 |
–2,824 |
–7,366 |
Purchase of treasury shares |
|
– |
–2,618 |
Interest paid |
|
–9,219 |
–8,865 |
Dividends paid to owners of the parent |
25 |
–32,460 |
–25,300 |
Acquisition of non-controlling interests |
20 |
– |
–7,967 |
|
|
|
|
Net cash from/(used in) financing activities |
|
–79,200 |
–69,977 |
|
|
|
|
Net (decrease)/increase in cash and cash equivalents |
|
132,845 |
165,127 |
Cash and cash equivalents at beginning of period |
|
313,490 |
154,142 |
Net foreign exchange difference on cash and cash equivalents |
|
–11,394 |
–5,779 |
|
|
|
|
Cash and cash equivalents at end of period |
|
434,941 |
313,490 |
1) Prior-year figures restated, refer to Note 2 Change in presentation.